BioCentury
ARTICLE | Company News

Onset Therapeutics, Oculus sales and marketing update

November 15, 2010 8:00 AM UTC

Onset and Oculus partnered to bring dermatology products to the U.S. market, initially targeting atopic dermatitis and related conditions. The companies will use Oculus' Microcyn technology platform ...